Home / Intelligence /

Search

Blog

RWD + PMR = Tethering Demand Forecasts to Reality

Published April 30, 2024

Reliable forecast models are a cornerstone of any successful commercialization plan. The inputs that drive those forecast models are critical. From 2020 through 2022: Only 1 in 10 products had performance aligned with forecasted expectations* Nearly 60% underperformed their forecast expectations More than 30% overperformed Forecast models often rely on healthcare professional (HCP)-reported behavioral data. Various subjective calibration factors are required to render the data usable, even after implementing robust market research design elements. Data from primary market research (PMR)…

Read Now

Webinars

RWD + PMR: A Powerful Approach to Demand Forecasting, Segmentation and More

Available On Demand

Predictive insights on stakeholder behavior are crucial, whether for demand assessments, segmentation, message testing, market mapping or ATUs—and the more rooted in reality these predictions are, the more confidence in the estimates and outputs. Join Trinity Insights experts Clive Mendonca, Managing Director & Head of Quantitative Insights and Amod Athavale, Director & Head of Integrated Insights as they lead a lively discussion of the applications and benefits of using integrated insights from PMR and real-world data (RWD). Key Webinar Topics…

Watch Now

White Papers

Tethering to Reality: Integrating HCP-level Real-World Data into Brand Share Estimation

Share estimates from demand studies in primary market research (PMR) are a critical input for any forecast—their accuracy is paramount for successful brand planning. Successful prediction is often elusive—from 2020 through 2022, only one in ten products had actual performance that aligned with forecasted expectations.* Recognizing this challenge, Trinity experts developed a method that significantly improves prediction of future prescribing behavior in demand studies. The Challenge It is often difficult for Healthcare Professionals (HCPs) to offer precise share estimates when…

Read Now

Webinars

Patient Finding with AIML: Increasing Targeting Precision and Field Force Pull Through

Available On Demand

There are four key pieces to Patient Finding: Identifying, collating and integrating the right data Defining the appropriate test population Building the right features in the model Planning and executing actions once you’ve found the patients All four are crucial to successfully find patients. Join Adrienne Lovink, Partner and Head of Real-World Evidence (RWE) at Trinity Life Sciences, as she hosts a lively discussion on the ins and outs of Patient Finding with Trinity panelists Steve Laux, Vice President of…

Watch Now

Webinars

Generating Robust Insights to Develop a Compelling Value Story with RWE

Available On Demand

The unprecedented availability of rich RWE data sources gives HEOR, Value and Access and Medical leaders the opportunity to be more intentional than ever before. High-quality, compelling evidence is now a necessity, not just for high-value therapies playing in the rare disease space—but also more broadly, to show reduced unmet needs, health care resource utilization (HCRU) and cost offsets. Deep experience using industry-leading data sources, tech-enabled methodologies and therapeutic expertise allow Trinity experts to choose the right data for each…

Watch Now

Blog

Mapping the Unknown: Measuring Cell and Gene Therapy Adoption Using Real-World Evidence

Published August 9, 2022

It’s been 10 years since the first pediatric patient was treated with chimeric antigen receptor T-cell (CAR-T) therapy for her acute lymphoblastic leukemia. At the time, the approach to engineer immune cells was a novel, ground-breaking concept. In the subsequent decade, research into this space had continued to advance. Equally importantly, the patient has remained cancer-free, serving as one of the most visible examples of the impact this type of therapeutic may have for patients with complex or difficult to…

Read Now

Webinars

Make Rapid Decisions with Confidence: Trinity’s Approach to Business Development Assessments

Available On Demand

Life science companies are often faced with situations that require quick decisions—from triage and/or pre-diligence phases through full due diligence. Trinity’s expert team routinely provides time-sensitive business development support, delivering robust insights and evidence-based answers in days. Come join us for a dynamic discussion on evaluating Business Development opportunities in life sciences. Key Webinar Topics What are the best approaches, data and tools to meet your business needs within your time horizon? How can you leverage rapid access to Real-World…

Watch Now